Study of Oral Venetoclax Tablets in Combination With Intravenous Obinutuzumab Injection to Assess Achievement of Best Response in Adult Participants With Chronic Lymphocytic Leukemia

NCT04655261 · clinicaltrials.gov ↗

TERMINATED

Status

5

Enrollment

INDUSTRY

Sponsor class

Stopped Lack of Recruitment

Conditions

Chronic Lymphocytic Leukemia (CLL)

Sponsor

AbbVie